Companies: 10,795·Total market cap: $144.5T
Quest Diagnostics Incorporated

Quest Diagnostics Incorporated

DGXNYSEHealthcare● Active
$200.29
+$4.17(+2.13%)
Market Cap$22.2B
P/E Ratio
52W High$213.5
52W Low$164.65
Overview

Quest Diagnostics Incorporated (DGX) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · DGX · as of Jun 8, 2026

Key Statistics

EPS (TTM)$9.17dgx eps ttm · dgx earnings per shareEarnings history
PE Ratio (TTM)21.8×dgx pe ratio ttm · dgx price to earningsPE Ratio deep dive
Revenue (TTM)$11.3Bdgx revenue ttm · dgx annual revenueFull revenue history
Dividend Yield1.66%does dgx pay dividends · dgx dividend yieldDividend history
Shares Outstanding111.0Mdgx shares outstanding · dgx floatShares outstanding history
Next EarningsJul 28, 2026Est.dgx earnings date · dgx next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$11.04B▲ +11.78% YoY
202320242025
quest diagnostics incorporated revenue · dgx revenue 2025
FY 2025Net Income$992.0M▲ +13.89% YoY
202320242025
quest diagnostics incorporated net income · dgx profit 2025
FY 2025EPS$8.87▲ +13.72% YoY
202320242025
dgx eps · quest diagnostics incorporated earnings per share 2025
TTM:Revenue: $11.28BNet Income: $1.02BEPS: $9.17View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Hold34 analystsis dgx a buy · dgx analyst rating
Strong Buy
0
Buy
13
Hold
18
Sell
3
Strong Sell
0
12-Month Price Target
$210.00Low
$200.29Current
$220.57Avg Target10.13% upside
$235.00High
dgx price target · dgx 12 month forecast

Total: 34 · Buy rate: 38.2%

The DGX analyst consensus is Hold, based on ratings from 34 Wall Street analysts over the past 3 months. The average 12-month price target is $220.57, representing +10.13% upside from the current price of $200.29.

Stock Performance

Full History
1D+2.13%
1W+3.78%
1M+6.88%
3M+0.54%
YTD+15.42%
1Y+13.87%
5Y+57.07%

About Quest Diagnostics Incorporated

CEOJames E. Davis
IPO DateDec 17, 1996
Employees55,000
CountryUS

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such …

what is quest diagnostics incorporated · dgx stock overview · quest diagnostics incorporated company profile · who is quest diagnostics incorporated ceo · dgx NYSE · quest diagnostics incorporated headquarters · quest diagnostics incorporated business segments

About Stock Overview & Key Data

Quest Diagnostics Incorporated (DGX) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NYSE since Dec 17, 1996. As of the latest trading session, DGX stock price is $200.29, with a market capitalization of $22.2B. The stock has returned +13.87% over the past 12 months and +15.42% year-to-date.

According to 34 Wall Street analysts, the consensus rating for Quest Diagnostics Incorporated stock is Hold, with an average 12-month price target of $220.57. In fiscal year 2025, Quest Diagnostics Incorporated reported revenue of $11.0B and net income of $992.0M. For detailed data — including Quest Diagnostics Incorporated revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Quest Diagnostics Incorporated (DGX) stock price is $200.29. The stock is traded on NYSE under the ticker symbol DGX. The 52-week range is $164.65 – $213.50.

DGX stock priceDGX quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice